ACOG:Preparing for Disasters: Addressing Critical Obstetric and Gynecologic Needs of Patients – ACOG Committee Statement No. 15

Article Link Abstract Large-scale catastrophic events, either natural or human-influenced, highlight the requisite for emergency plans that specifically address the needs of obstetric and gynecologic patients. Pregnant, postpartum, and lactating…

Read More from ACOG:Preparing for Disasters: Addressing Critical Obstetric and Gynecologic Needs of Patients – ACOG Committee Statement No. 15

ACOG: Management of Full-Term Nulliparous Individuals Without a Medical Indication for Delivery – ACOG Clinical Practice Update

Article Link Abstract This Clinical Practice Update integrates data from a large, randomized controlled trial (the ARRIVE trial [A Randomized Trial of Induction Versus Expectant Management]) and subsequent other related…

Read More from ACOG: Management of Full-Term Nulliparous Individuals Without a Medical Indication for Delivery – ACOG Clinical Practice Update

ACOG: Betamethasone Exposure and Neonatal Respiratory Morbidity Among Late Preterm Births by Planned Mode of Delivery and Gestational Age

Article Link OBJECTIVE:  To estimate the effect of late preterm antenatal steroids on the risk of respiratory morbidity among subgroups of patients on the basis of the planned mode of…

Read More from ACOG: Betamethasone Exposure and Neonatal Respiratory Morbidity Among Late Preterm Births by Planned Mode of Delivery and Gestational Age

ACOG: Changes in Prenatal Cannabis Use Among Pregnant Individuals From 2012 to 2022

https://journals.lww.com/greenjournal/fulltext/2024/10000/changes_in_prenatal_cannabis_use_among_pregnant.17.aspx Abstract This population-based cross-sectional study analyzed electronic health record data of pregnant individuals in an integrated health care delivery system in California to examine changes in prenatal cannabis use…

Read More from ACOG: Changes in Prenatal Cannabis Use Among Pregnant Individuals From 2012 to 2022

ACOG: Addressing Social and Structural Determinants of Health in the Delivery of Reproductive Health Care

ACOG Committee Statement No. 11 https://journals.lww.com/greenjournal/fulltext/2024/11000/addressing_social_and_structural_determinants_of.27.aspx Abstract Social and structural determinants of health include historical, social, political, and economic forces, many of which are rooted in racism and inequality, that…

Read More from ACOG: Addressing Social and Structural Determinants of Health in the Delivery of Reproductive Health Care

ACOG: Long-Term Risk of Type 2 Diabetes After Preterm Delivery or Hypertensive Disorders of Pregnancy

https://journals.lww.com/greenjournal/abstract/2024/11000/long_term_risk_of_type_2_diabetes_after_preterm.14.aspx OBJECTIVE:  To examine long-term diabetes risk after preterm delivery or hypertensive disorders of pregnancy in a large population-based cohort. METHODS:  This retrospective cohort study included all women with a…

Read More from ACOG: Long-Term Risk of Type 2 Diabetes After Preterm Delivery or Hypertensive Disorders of Pregnancy

ACOG: Continuous Glucose Monitoring for Management of Type 2 Diabetes and Perinatal Outcomes

https://journals.lww.com/greenjournal/fulltext/2024/11000/continuous_glucose_monitoring_for_management_of.12.aspx OBJECTIVE:  To evaluate the association between continuous glucose monitoring in pregnant people with type 2 diabetes and perinatal outcomes. METHODS:  This was a retrospective cohort study of pregnant people…

Read More from ACOG: Continuous Glucose Monitoring for Management of Type 2 Diabetes and Perinatal Outcomes

ACOG: Association Between Metformin Use in Early Gestational or Type 2 Diabetes in Pregnancy and Preterm Preeclampsia

https://journals.lww.com/greenjournal/abstract/2024/11000/association_between_metformin_use_in_early.18.aspx OBJECTIVE:  To estimate the association between maternal metformin use for the treatment of early gestational or pre-existing type 2 diabetes and preterm preeclampsia. METHODS:  This is a planned secondary…

Read More from ACOG: Association Between Metformin Use in Early Gestational or Type 2 Diabetes in Pregnancy and Preterm Preeclampsia

ACOG Clinical Practice Update: Screening for Gestational and Pregestational Diabetes in Pregnancy and Postpartum

https://journals.lww.com/greenjournal/abstract/9900/screening_for_gestational_and_pregestational.1074.aspx Abstract This Clinical Practice Update reviews current data on screening and diagnostic criteria for pregestational and gestational diabetes mellitus during pregnancy and type 2 diabetes mellitus postpartum. This document…

Read More from ACOG Clinical Practice Update: Screening for Gestational and Pregestational Diabetes in Pregnancy and Postpartum

ACOG: Pre-existing Diabetes and Stillbirth or Perinatal Mortality: A Systematic Review and Meta-analysis

https://journals.lww.com/greenjournal/abstract/9900/pre_existing_diabetes_and_stillbirth_or_perinatal.1125.aspx OBJECTIVE:  Despite the well-recognized association between pre-existing diabetes mellitus and stillbirth or perinatal mortality, there remain knowledge gaps about the strength of association across different populations. The primary objective…

Read More from ACOG: Pre-existing Diabetes and Stillbirth or Perinatal Mortality: A Systematic Review and Meta-analysis

ACOG: Association Between Metformin Use in Early Gestational or Type 2 Diabetes in Pregnancy and Preterm Preeclampsia

https://journals.lww.com/greenjournal/abstract/9900/association_between_metformin_use_in_early.1144.aspx OBJECTIVE:  To estimate the association between maternal metformin use for the treatment of early gestational or pre-existing type 2 diabetes and preterm preeclampsia. METHODS:  This is a planned secondary…

Read More from ACOG: Association Between Metformin Use in Early Gestational or Type 2 Diabetes in Pregnancy and Preterm Preeclampsia

ACOG: Association Between Novel Antiphospholipid Antibodies and Adverse Pregnancy Outcomes

https://journals.lww.com/greenjournal/abstract/9900/association_between_novel_antiphospholipid.1154.aspx OBJECTIVE:  To investigate the value of anti-β2 glycoprotein-I domain 1 (aD1) and antiphosphatidylserine–prothrombin antibodies for predicting adverse pregnancy outcomes in an at-risk population and to describe the relationship among…

Read More from ACOG: Association Between Novel Antiphospholipid Antibodies and Adverse Pregnancy Outcomes

ACOG: Magnesium Sulfate Before Preterm Birth for Neuroprotection – An Updated Cochrane Systematic Review

https://journals.lww.com/greenjournal/fulltext/2024/08000/magnesium_sulfate_before_preterm_birth_for.7.aspx OBJECTIVE:  To systematically review the evidence for the effectiveness and safety of magnesium sulfate as a fetal neuroprotective agent when given to individuals at risk of preterm birth. DATA…

Read More from ACOG: Magnesium Sulfate Before Preterm Birth for Neuroprotection – An Updated Cochrane Systematic Review

ACOG: Evaluation of Statewide Program to Reduce Cesarean Deliveries Among Nulliparous Individuals With Singleton Pregnancies at Term Gestation in Vertex Presentation

Obstetrics & Gynecology (lww.com) OBJECTIVE:  To evaluate the effect of statewide efforts to reduce nulliparous, term, singleton, vertex (NTSV) cesarean delivery rates in California. METHODS:  This was a population-based study…

Read More from ACOG: Evaluation of Statewide Program to Reduce Cesarean Deliveries Among Nulliparous Individuals With Singleton Pregnancies at Term Gestation in Vertex Presentation

ACOG: Congenital Syphilis in Live Births – Adverse Outcomes, Hospital Length of Stay, and Costs

Obstetrics & Gynecology (lww.com) OBJECTIVE:  To examine temporal trends and risk factors for congenital syphilis in newborn hospitalizations and to evaluate the association between adverse outcomes and congenital syphilis and…

Read More from ACOG: Congenital Syphilis in Live Births – Adverse Outcomes, Hospital Length of Stay, and Costs

ACOG: Immediate Postpartum Long-Acting Reversible Contraception for Preventing Severe Maternal Morbidity – A Cost-Effective Analysis

Obstetrics & Gynecology (lww.com) OBJECTIVE:  To estimate the cost effectiveness of Medicaid covering immediate postpartum long-acting reversible contraception (LARC) as a strategy to reduce future short interpregnancy interval (IPI), severe…

Read More from ACOG: Immediate Postpartum Long-Acting Reversible Contraception for Preventing Severe Maternal Morbidity – A Cost-Effective Analysis

ACOG: Optimizing Opioid Prescription Quantity After Cesarean Delivery – A Randomized Controlled Trial

Obstetrics & Gynecology (lww.com) OBJECTIVE:  To test whether an individualized opioid-prescription protocol (IOPP) with a shared decision-making component can be used without compromising postcesarean pain management. METHODS:  In this multicenter…

Read More from ACOG: Optimizing Opioid Prescription Quantity After Cesarean Delivery – A Randomized Controlled Trial

ACOG Clinical Practice Update: Update on Criteria for Suspected Diagnosis of Intraamniotic Infection

Obstetrics & Gynecology (lww.com) CLINICAL RECOMMENDATIONSIn summary, although the diagnosis of suspected intraamniotic infection frequently includes maternal fever as a clinical criterion, scenarios exist in which fever in patients with…

Read More from ACOG Clinical Practice Update: Update on Criteria for Suspected Diagnosis of Intraamniotic Infection

ACOG Clinical Practice Update: Screening for Gestational and Pregestational Diabetes in Pregnancy and Postpartum

Obstetrics & Gynecology (lww.com) CLINICAL RECOMMENDATIONSDiabetes Mellitus Screening at Less Than 24 Weeks of GestationDue to the lack of consistent evidence to indicate neonatal and maternal benefit from early diagnosis…

Read More from ACOG Clinical Practice Update: Screening for Gestational and Pregestational Diabetes in Pregnancy and Postpartum